These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 659964)

  • 21. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of platelet prostaglandin production in the platelet dense tubular system.
    Gerrard JM; White JG; Rao GH; Townsend D
    Am J Pathol; 1976 May; 83(2):283-98. PubMed ID: 1266944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
    Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
    Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the role of arachidonic acid in platelet function and mechanisms for suppression of prostaglandin biosynthesis.
    Huzoor-Akbar ; Ardlie NG
    Br J Haematol; 1978 May; 39(1):71-81. PubMed ID: 666979
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.
    Ali M; McDonald JW
    J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of heterologous antibody on human platelet prostaglandin synthesis.
    Favis GR; Colman RW
    Immunol Commun; 1980; 9(1):13-22. PubMed ID: 7364455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet function in hyperbetalipoproteinemia.
    Colman RW
    Thromb Haemost; 1978 Apr; 39(2):284-93. PubMed ID: 580982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of levamisole on aggregation of platelets stimulated with compounds associated with the prostaglandin synthetic pathway.
    Hokama Y; Morita AH; Abad MA; Joyo BS; Uchida DA; Fischer GW
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):141-9. PubMed ID: 625583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the abilities of acetylsalicylic acid, flurbiprofen and indomethacin to inhibit the release reaction and prostaglandin synthesis in human blood platelets.
    Cockbill SR; Heptinstall S; Taylor PM
    Br J Pharmacol; 1979 Sep; 67(1):73-8. PubMed ID: 115531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin E and platelet function.
    Stuart MJ; Oski FA
    Am J Pediatr Hematol Oncol; 1979; 1(1):77-82. PubMed ID: 396795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemiluminescence response of human platelets.
    Mills EL; Gerrard JM; Filipovich D; White JD; Quie PG
    J Clin Invest; 1978 Mar; 61(3):807-14. PubMed ID: 641157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade.
    Rao GH; Reddy RK; White JG
    Prostaglandins Med; 1981 May; 6(5):485-94. PubMed ID: 6115432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of halofenate on triglyceride and uric acid levels, coagulation and platelet behaviour in patients with hyperlipoproteinemia type IV and hyperuricemia (author's transl)].
    Kuntzen O; Hehl FJ; Walter E; Zimmermann R
    Arzneimittelforschung; 1978; 28(12):2349-52. PubMed ID: 227420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyridoxal phosphate inhibition of platelet function.
    Kornecki E; Feinberg H
    Am J Physiol; 1980 Jan; 238(1):H54-60. PubMed ID: 6766674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of certain antiplatelet drugs on in vitro malonylaldehyde (MDA) production.
    Fabris F; Casonato A; De Marco L; Girolami A
    Arzneimittelforschung; 1979; 29(7):981-3. PubMed ID: 583000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.